Search results
Kyle Rittenhouse slammed over message about USA
Newsweek· 24 minutes agoKyle Rittenhouse has been hit with a wave of criticism on social media after saying a group of Native Americans should leave the United States. Rittenhouse made the remark in response to a viral ...
50% of Americans Won't Be Able to Afford Their Standard of Living in Retirement: Here's What You Can...
SmartAsset via Yahoo Finance· 53 minutes agoWill you have to downsize in your retirement? Many families plan to adjust their lifestyles in...
Finding Undiagnosed Asthma, COPD and Treating It Shows Benefit in Trial
MedPage Today· 1 day agoThe study first identified more than 500 adults with undiagnosed asthma or COPD via targeted case-...
Auburn running back Brian Battie on ventilator after weekend shooting in Florida, coach says
WINK TV Southwest Florida· 1 hour agoThe Sarasota County Sheriff’s office said they responded to a strip mall at about 3:30 a.m....
Panthers named best fit for free-agent CB Stephon Gilmore
Panthers Wire via Yahoo Sports· 2 hours agoWell, ESPN’s Matt Bowen would agree. Bowen played matchmaker on Monday, finding the best fits for...
Eastman (EMN) Partners Debrand to Recycle Textile Waste
Zacks via Yahoo Finance· 4 hours agoEastman Chemical Company EMN, which produces Naia cellulosic fibers, has formed a strategic...
Tesla Shareholders Are Voting On Elon Musk's Pay Package. What We Know And What's At Stake.
Investor's Business Daily· 1 hour agoThe stock is down 4.5% in May and has sunk around 30% on the year. Tesla reported first quarter...
Trump Media lost $327 million last quarter
Quartz· 1 hour agoTrump Media & Technology Group reported a loss before income taxes of $327.6 million last quarter, as the company behind former President Donald Trump’s...
Report Reveals 'Catastrophic Decline' of Migratory Fish
Yale Environment 360 via Yahoo News· 46 minutes agoHumans are driving the losses by overfishing, polluting waterways, damming rivers, converting...
ZYMFENTRA™ (infliximab-dyyb) demonstrated long-term efficacy and safety profile of maintenance...
Benzinga· 9 hours agoFindings from the extended LIBERTY studies and associated post-hoc analysis support the long-term efficacy and safety of ZYMFENTRA™, the first and only FDA-approved subcutaneous infliximab[1],[2]Data from a
